Clinical Trial Update: Liver Transplant European Study Into the Prevention of Fungal Infection [Phase 3]

View source ↗

Summary

Phase 3 European trial in liver transplant patients evaluated micafungin (Mycamine) for prevention of fungal infection; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycoses

Drugs mentioned

• Mycamine (Micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Liver Transplantation, Mycoses | Phase 3 | Status: COMPLETED